Crossject Société Anonyme (ENXTPA: ALCJ)
Health Care · Health Care Equipment & Supplies · FR
€1.39
-1.56% today · -10.3% 1Y
Crossject Société Anonyme (ENXTPA: ALCJ) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $89.74M and employs 99 people.
Over the last twelve months the share price has lost 10.3%, trading between 1.35 and 2.70.
Tweenvest scores Crossject Société Anonyme across four factors: quality 11/100, value 56/100, growth 0/100. Its strongest factor is value.
ALCJ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $89.74M
- Revenue (TTM)
- $3.02M
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- 0.50
- 52-week high
- €2.70
- 52-week low
- €1.35
- Avg volume (3M)
- —
- Shares outstanding
- 54.44M
- Employees
- 99
- Next earnings
- —
About Crossject Société Anonyme
Crossject S.A. is dedicated to pioneering needle-free drug delivery solutions. A key innovation from the company is ZENEO, a prefilled, single-use auto-injector that eliminates the need for a traditional needle. Crossject is actively advancing a portfolio of drugs through clinical trials, all intended for administration via its ZENEO system. This pipeline includes Sumatriptan for treating migraines and cluster headaches, Adrenaline for severe allergic reactions (anaphylactic shock), Hydrocortisone for acute adrenal insufficiency, Midazolam for managing epileptic seizures, Naloxone for opioid overdose, Apomorphine for temporary paralysis in Parkinson's patients, Methotrexate for rheumatoid arthritis, and Terbutaline for acute asthma attacks. Founded in 1997, the company maintains its operational base in Dijon, France.
- ISIN
- FR0011716265
- Founded
- 2001
- Listed since
- Feb 20, 2014
- Exchange
- Euronext Paris
- Currency
- EUR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.85 | +0.18% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $380.60 | +0.47% |
| Stryker CorporationNYSE: SYK | $126.37B | $332.00 | +0.77% |
| Medtronic plcNYSE: MDT | $119.49B | $93.79 | +0.47% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €162.35 | -0.52% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.74 | +0.73% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.